Genpact Limited (NYSE:G - Get Free Report) declared a quarterly dividend on Thursday, July 10th, RTT News reports. Investors of record on Thursday, September 11th will be paid a dividend of 0.17 per share by the business services provider on Thursday, September 25th. This represents a $0.68 annualized dividend and a dividend yield of 1.53%. The ex-dividend date is Thursday, September 11th.
Genpact has a dividend payout ratio of 18.2% indicating that its dividend is sufficiently covered by earnings. Research analysts expect Genpact to earn $3.49 per share next year, which means the company should continue to be able to cover its $0.68 annual dividend with an expected future payout ratio of 19.5%.
Genpact Trading Down 2.2%
Shares of G traded down $1.00 on Friday, hitting $44.30. 1,127,913 shares of the stock traded hands, compared to its average volume of 1,420,223. The company has a quick ratio of 2.45, a current ratio of 2.45 and a debt-to-equity ratio of 0.48. The firm has a market capitalization of $7.75 billion, a P/E ratio of 14.82, a P/E/G ratio of 1.93 and a beta of 0.94. The stock's 50 day moving average is $43.93 and its two-hundred day moving average is $47.06. Genpact has a 1 year low of $32.18 and a 1 year high of $56.76.
Genpact (NYSE:G - Get Free Report) last issued its quarterly earnings results on Wednesday, May 7th. The business services provider reported $0.84 EPS for the quarter, topping the consensus estimate of $0.80 by $0.04. Genpact had a net margin of 10.88% and a return on equity of 22.35%. The firm had revenue of $1.21 billion during the quarter, compared to analyst estimates of $1.21 billion. During the same quarter in the prior year, the business posted $0.73 earnings per share. Genpact's revenue for the quarter was up 7.4% compared to the same quarter last year. As a group, sell-side analysts predict that Genpact will post 3.21 earnings per share for the current year.
Insider Buying and Selling at Genpact
In other news, Director Nicholas C. Gangestad acquired 2,000 shares of the company's stock in a transaction that occurred on Tuesday, May 13th. The shares were acquired at an average price of $43.97 per share, with a total value of $87,940.00. Following the acquisition, the director directly owned 2,000 shares in the company, valued at approximately $87,940. The trade was a ∞ increase in their ownership of the stock. The acquisition was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this hyperlink. 3.07% of the stock is currently owned by company insiders.
Hedge Funds Weigh In On Genpact
Institutional investors and hedge funds have recently bought and sold shares of the stock. Goldman Sachs Group Inc. boosted its position in shares of Genpact by 20.8% during the 1st quarter. Goldman Sachs Group Inc. now owns 353,074 shares of the business services provider's stock valued at $17,788,000 after purchasing an additional 60,887 shares in the last quarter. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC boosted its holdings in shares of Genpact by 12.4% in the first quarter. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC now owns 511,627 shares of the business services provider's stock worth $25,776,000 after buying an additional 56,557 shares during the period. Royal Bank of Canada boosted its holdings in shares of Genpact by 19.7% in the first quarter. Royal Bank of Canada now owns 121,705 shares of the business services provider's stock worth $6,131,000 after buying an additional 20,043 shares during the period. Amundi purchased a new position in shares of Genpact in the first quarter worth approximately $58,000. Finally, Focus Partners Wealth increased its position in shares of Genpact by 10.3% in the first quarter. Focus Partners Wealth now owns 5,227 shares of the business services provider's stock worth $263,000 after acquiring an additional 488 shares in the last quarter. Institutional investors own 96.03% of the company's stock.
Analyst Ratings Changes
G has been the subject of several research reports. Needham & Company LLC reiterated a "buy" rating and set a $50.00 price objective on shares of Genpact in a research note on Monday, June 30th. Wall Street Zen upgraded shares of Genpact from a "buy" rating to a "strong-buy" rating in a research note on Friday, June 6th. Mizuho upped their target price on shares of Genpact from $48.00 to $51.00 and gave the company a "neutral" rating in a research note on Tuesday, July 1st. Finally, Robert W. Baird decreased their target price on shares of Genpact from $56.00 to $50.00 and set a "neutral" rating for the company in a research note on Thursday, May 8th. Four analysts have rated the stock with a hold rating, three have given a buy rating and one has given a strong buy rating to the company. According to data from MarketBeat.com, Genpact currently has an average rating of "Moderate Buy" and a consensus price target of $50.14.
Read Our Latest Analysis on G
Genpact Company Profile
(
Get Free Report)
Genpact Limited provides business process outsourcing and information technology services in India, rest of Asia, North and Latin America, and Europe. It operates through three segments: Financial services; Consumer and Healthcare; and High Tech and Manufacturing. The Financial Services segment offers retail customer onboarding, customer service, collections, card servicing operations, loan and payment operations, commercial loan, equipment and auto loan, mortgage origination, compliance services, reporting and monitoring, and wealth management operations support; financial crime and risk management services; and underwriting support, new business processing, policy administration, claims management, catastrophe modeling and actuarial services, as well as property and casualty claims.
Read More

Before you consider Genpact, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Genpact wasn't on the list.
While Genpact currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Market downturns give many investors pause, and for good reason. Wondering how to offset this risk? Enter your email address to learn more about using beta to protect your portfolio.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.